Rapid Communication
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Dec 21, 2008; 14(47): 7240-7246
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7240
Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
Hai-Ning Wang, Yan-Rong Wang, Guo-Qiang Liu, Zhe Liu, Pei-Xian Wu, Xiao-Ling Wei, Tian-Pei Hong
Hai-Ning Wang, Yan-Rong Wang, Guo-Qiang Liu, Zhe Liu, Pei-Xian Wu, Xiao-Ling Wei, Tian-Pei Hong, Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China
Author contributions: Wang HN and Wang YR contributed equally to this work. Wang YR and Hong TP designed the research; Wang HN, Liu Z, Wu PX, and Wei XL performed the research; Hong TP, Wang HN and Liu GQ analyzed the data and wrote the paper.
Supported by The National Natural Science Foundation of China, No. 30771032 and No. 30700879, the National 973 Program of China, No. 2006CB503900, the National 863 Program of China, No. 2006AA02A112, and the Natural Science Foundation of Beijing City, No. 7062067
Correspondence to: Tian-Pei Hong, MD, PhD, Professor, Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China. tpho66@bjmu.edu.cn
Telephone: +86-10-82265515 Fax: +86-10-62017700
Received: August 25, 2008
Revised: November 11, 2008
Accepted: November 18, 2008
Published online: December 21, 2008
Core Tip